Literature DB >> 23643626

Febrile infection-related epilepsy syndrome: a study of 12 patients.

Roberto H Caraballo1, Gabriela Reyes, Maria Francisca Lopez Avaria, Maria Celeste Buompadre, Mariana Gonzalez, Sebastian Fortini, Ricardo Cersosimo.   

Abstract

PURPOSE: To analyze the electroclinical features, neuroimaging findings, treatment, and outcome of 12 patients with febrile infection-related epilepsy syndrome (FIRES).
METHODS: This is a retrospective study of 12 children with FIRES with a mean time of follow-up of 6.5 years carried out at the Garrahan Hospital of Buenos Aires between 1997 and 2012.
RESULTS: Eight males and four females had focal status epilepticus preceded by febrile infection with a mean age at presentation of 8.5 years. In the acute period, the treatment included antiepileptic drugs (AEDs) in all cases, immunotherapy in 10 cases, and burst-suppression coma in eight. The ketogenic diet was tried in two, plasmapheresis in one, and rituximab in one. Two patients treated with IVIG and one patient given steroids had a good response, but in this phase only three patients had a prolonged good response to IVIG and a ketogenic diet. No patients died in this period. In the chronic epilepsy phase, all children had seizures arising from neocortical regions. All patients had refractory epilepsy, and most mental retardation, and behavioral disturbances. All received different AEDs and in this phase a third patient was put on a ketogenic diet. One patient was operated without good results. Only two cases had a good outcome after 2 and 10 years of follow-up.
CONCLUSION: FIRES is a well-defined severe epileptic syndrome, probably in the group of epileptic encephalopathies, characterized by focal or multifocal seizures arising from the neocortical regions with an unknown etiology. Immunoglobulin and the ketogenic diet may be considered a potentially efficacious treatment.
Copyright © 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Encephalopathy; Epilepsy; Febrile; Focal status epilepticus; Neocortical; Refractory

Mesh:

Substances:

Year:  2013        PMID: 23643626     DOI: 10.1016/j.seizure.2013.04.005

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  11 in total

1.  Dietary Management of Children With Super-Refractory Status Epilepticus: A Systematic Review and Experience in a Single UK Tertiary Centre.

Authors:  Natasha E Schoeler; Zoe Simpson; Runming Zhou; Suresh Pujar; Christin Eltze; J H Cross
Journal:  Front Neurol       Date:  2021-03-12       Impact factor: 4.003

Review 2.  Recognizing Autoimmune-Mediated Encephalitis in the Differential Diagnosis of Limbic Disorders.

Authors:  A J da Rocha; R H Nunes; A C M Maia; L L F do Amaral
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-17       Impact factor: 3.825

Review 3.  Febrile Seizures and Febrile Seizure Syndromes: An Updated Overview of Old and Current Knowledge.

Authors:  Abdulhafeez M Khair; Dalal Elmagrabi
Journal:  Neurol Res Int       Date:  2015-11-30

4.  Marked improvement in febrile infection-related epilepsy syndrome after lidocaine plus MgSO4 treatment in a 12-year-old girl.

Authors:  I-Ching Chou; Huan-Cheng Lai; Fuu-Jen Tsai; Yu-Tzu Chang; Sheng-Shing Lin; Syuan-Yu Hong; Inn-Chi Lee
Journal:  Epilepsy Behav Case Rep       Date:  2016-06-02

5.  Use of Magnesium Sulfate Infusion for the Management of Febrile Illness-Related Epilepsy Syndrome: A Case Series.

Authors:  Wei Wei Tan; Derrick W S Chan; Jan Hau Lee; Terrence Thomas; Anuradha P Menon; Yoke Hwee Chan
Journal:  Child Neurol Open       Date:  2015-03-23

6.  Optimal clinical management of children receiving ketogenic parenteral nutrition: a clinical practice guide.

Authors:  Elles van der Louw; Vanessa Aldaz; Jessica Harvey; Marian Roan; Dorine van den Hurk; J Helen Cross; Stéphane Auvin
Journal:  Dev Med Child Neurol       Date:  2019-07-16       Impact factor: 5.449

Review 7.  Application of ketogenic diets for pediatric neurocritical care.

Authors:  Kuang-Lin Lin; Jann-Jim Lin; Huei-Shyong Wang
Journal:  Biomed J       Date:  2020-07-05       Impact factor: 4.910

Review 8.  Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life-Sustaining Therapies: A Systematic Review.

Authors:  Laurent M Willems; Sebastian Bauer; Kolja Jahnke; Martin Voss; Felix Rosenow; Adam Strzelczyk
Journal:  CNS Drugs       Date:  2020-08       Impact factor: 5.749

Review 9.  Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy.

Authors:  Gaku Yamanaka; Yu Ishida; Kanako Kanou; Shinji Suzuki; Yusuke Watanabe; Tomoko Takamatsu; Shinichiro Morichi; Soken Go; Shingo Oana; Takashi Yamazaki; Hisashi Kawashima
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

10.  Proposal to optimize evaluation and treatment of Febrile infection-related epilepsy syndrome (FIRES): A Report from FIRES workshop.

Authors:  Sookyong Koh; Elaine Wirrell; Annamaria Vezzani; Rima Nabbout; Eyal Muscal; Marios Kaliakatsos; Ronny Wickström; James J Riviello; Andreas Brunklaus; Eric Payne; Antonio Valentin; Elizabeth Wells; Jessica L Carpenter; Kihyeong Lee; Yi-Chen Lai; Krista Eschbach; Craig A Press; Mark Gorman; Coral M Stredny; William Roche; Tara Mangum
Journal:  Epilepsia Open       Date:  2021-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.